Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Total Current Liabilities (2021 - 2026)

Biohaven has reported Total Current Liabilities over the past 6 years, most recently at $52.1 million for Q1 2026.

  • Quarterly results put Total Current Liabilities at $52.1 million for Q1 2026, down 68.25% from a year ago — trailing twelve months through Mar 2026 was $52.1 million (down 68.25% YoY), and the annual figure for FY2025 was $115.9 million, down 24.83%.
  • Total Current Liabilities reached $52.1 million in Q1 2026 per BHVN's latest filing, down from $115.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $164.0 million in Q1 2025 and bottomed at $28.4 million in Q3 2022.
  • Median Total Current Liabilities over the past 5 years was $113.0 million (2025), compared with a mean of $103.8 million.
  • The largest annual shift saw Total Current Liabilities surged 178.27% in 2024 before it crashed 68.25% in 2026.
  • Over 5 years, Total Current Liabilities stood at $90.0 million in 2022, then tumbled by 38.43% to $55.4 million in 2023, then soared by 178.27% to $154.2 million in 2024, then decreased by 24.83% to $115.9 million in 2025, then crashed by 55.08% to $52.1 million in 2026.
  • Business Quant data shows Total Current Liabilities for BHVN at $52.1 million in Q1 2026, $115.9 million in Q4 2025, and $113.0 million in Q3 2025.